160 related articles for article (PubMed ID: 35904852)
1. Special issue "The advance of solid tumor research in China": Discoidin domain receptor 2 promotes colorectal cancer metastasis by regulating epithelial mesenchymal transition via activating AKT signaling.
Xu X; Duan X; Wang S; Zhang Y; Gao Y; Xu X; Yeerkenbieke G; Zhou J; Li J
Int J Cancer; 2023 Jan; 152(1):51-65. PubMed ID: 35904852
[TBL] [Abstract][Full Text] [Related]
2. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Softness Promotes the Metastatic Potential of Large-Nucleated Colorectal Cancer Cells via the ErbB4-Akt1-Lamin A/C Signaling Pathway.
Li Y; Li Q; Mu L; Hu Y; Yan C; Zhao H; Mi Y; Li X; Tao D; Qin J
Int J Biol Sci; 2024; 20(7):2748-2762. PubMed ID: 38725859
[TBL] [Abstract][Full Text] [Related]
4. Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.
Schab AM; Greenwade MM; Stock E; Lomonosova E; Cho K; Grither WR; Noia H; Wilke D; Mullen MM; Hagemann AR; Hagemann IS; Thaker PH; Kuroki LM; McCourt CK; Khabele D; Powell MA; Mutch DG; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
Mol Cancer Res; 2023 Nov; 21(11):1234-1248. PubMed ID: 37527178
[TBL] [Abstract][Full Text] [Related]
5. Isobutyric acid promotes colorectal cancer metastasis through activating RACK1.
Chen J; Tang J; Wang H; Mei J; Wei X; Qin X; Lin Q; Huang Z; Tang W; Luo T
Cancer Sci; 2023 Oct; 114(10):3900-3913. PubMed ID: 37519194
[TBL] [Abstract][Full Text] [Related]
6. Ribosome production factor 2 homolog promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via AKT/Gsk-3β signaling pathway.
Li H; Hu X; Cheng C; Lu M; Huang L; Dou H; Zhang Y; Wang T
Biochem Biophys Res Commun; 2022 Mar; 597():52-57. PubMed ID: 35123266
[TBL] [Abstract][Full Text] [Related]
7. Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis.
Rozen EJ; Frantz W; Wigglesworth K; Vessella T; Zhou HS; Shohet JM
Mol Cancer Ther; 2024 Apr; ():. PubMed ID: 38670553
[TBL] [Abstract][Full Text] [Related]
8. Discoidin domain receptor 2 regulates aberrant mesenchymal lineage cell fate and matrix organization.
Pagani CA; Bancroft AC; Tower RJ; Livingston N; Sun Y; Hong JY; Kent RN; Strong AL; Nunez JH; Medrano JMR; Patel N; Nanes BA; Dean KM; Li Z; Ge C; Baker BM; James AW; Weiss SJ; Franceschi RT; Levi B
Sci Adv; 2022 Dec; 8(51):eabq6152. PubMed ID: 36542719
[TBL] [Abstract][Full Text] [Related]
9. A third Notch in colorectal cancer progression and metastasis.
Koch U; Radtke F
J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32852523
[TBL] [Abstract][Full Text] [Related]
10. Discoidin Domain Receptor 2, a Potential Therapeutic Target in Lung Fibrosis.
Borza CM; Pozzi A; Plosa EJ
Am J Respir Cell Mol Biol; 2018 Sep; 59(3):277-278. PubMed ID: 29924938
[No Abstract] [Full Text] [Related]
11. The survival of esophageal cancer by subtype in China with comparison to the United States.
An L; Zheng R; Zeng H; Zhang S; Chen R; Wang S; Sun K; Li L; Wei W; He J
Int J Cancer; 2023 Jan; 152(2):151-161. PubMed ID: 35913753
[TBL] [Abstract][Full Text] [Related]
12. Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.
Mui CW; Chan WN; Chen B; Cheung AH; Yu J; Lo KW; Ke H; Kang W; To KF
Int J Cancer; 2023 Feb; 152(4):558-571. PubMed ID: 35983734
[TBL] [Abstract][Full Text] [Related]
13. Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.
Gao G; Cui L; Zhou F; Jiang T; Wang W; Mao S; Wu F; Jiang F; Zhang B; Bei T; Xie W; Zhang C; Zhang H; Gao C; Zhao X; Bai Y; Zhou C; Ren S
Int J Cancer; 2023 Jan; 152(1):79-89. PubMed ID: 36062503
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy.
Chen W; Shi H; Liu Z; Yang F; Liu J; Zhang L; Wu Y; Xia Y; Ou Y; Li R; Zhang T; Zhang J; Ke X; Hu K; Yu J
Clin Cancer Res; 2023 Apr; 29(8):1484-1495. PubMed ID: 36735547
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of
Zhuang Y; Lan S; Zhong W; Huang F; Peng J; Zhang S
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672423
[TBL] [Abstract][Full Text] [Related]
17. Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential.
Zhang W; Yan Y; Peng J; Thakur A; Bai N; Yang K; Xu Z
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612282
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data.
Zhao J; Wu L; Hu C; Bi N; Wang L
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612272
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis.
Zou H; Lei Q; Yan X; Lai Y; Ung COL; Hu H
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612256
[TBL] [Abstract][Full Text] [Related]
20. Research Progress and Direction of Novel Organelle-Migrasomes.
Zhang Y; Zhang M; Xie Z; Ding Y; Huang J; Yao J; Lv Y; Zuo J
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
